Xtrackers MSCI Fintech Innovation UCITS ETF 1C

INVESTMENT OBJECTIVE: The aim is for your investment to track the performance before fees and expenses of the MSCI ACWI IMI Fintech Innovation Select Screened 100 Index (index). DESCRIPTION OF INDEX: The index is based on the MSCI ACWI IMI Index (Parent Index) and reflects the performance of large, medium, and small-capitalisation companies globally that derive significant revenues from technological innovation in the financial sector. Companies from the Parent Index that pass both thematic selection criteria and ESG screening criteria are eligible. The thematic selection criteria calculates a relevance score for potential constituents by assessing companies' exposure to business activities associated with the theme. Securities must meet a certain relevance score threshold to be eligible. ESG CRITERIA: The ESG screening criteria excludes companies from the Parent Index which breach certain ESG standards, as disclosed in the prospectus and/or supplement. The remaining securities are then ranked by their market capitalisation and the top 100 are selected for inclusion. Securities are weighted by a product of their market capitalisation and their relevance score. Each issuer is capped at 4.5% weight at each rebalance. INDEX REBALANCING, CALCULATION AND ADMINISTRATION: The index is administered by MSCI Limited. The index is calculated on a total return net basis, which means that all dividends and distributions by the companies are reinvested in the shares after tax. The index is reviewed semi-annually and rebalanced at least quarterly. The index is calculated in USD on a daily basis. INVESTMENT POLICY: To achieve the aim, the fund will attempt to replicate the index, before fees and expenses, by buying all or a substantial number of the securities in the index. The fund may employ techniques and instruments in order to manage risk, reduce costs and improve results. These techniques and instruments may include the use of financial contracts (derivatives). The fund may a

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No